ASTH
Price
$40.89
Change
+$1.30 (+3.28%)
Updated
Jun 23, 04:01 PM (EDT)
Capitalization
1.96B
50 days until earnings call
Intraday BUY SELL Signals
HCA
Price
$387.90
Change
+$10.91 (+2.89%)
Updated
Jun 23, 04:08 PM (EDT)
Capitalization
83.63B
30 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ASTH vs HCA

ASTH vs HCA Comparison Chart in %
View a ticker or compare two or three
VS
ASTH vs. HCA commentary
Jun 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASTH is a Hold and HCA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 23, 2026
Stock price -- (ASTH: $39.56 vs. HCA: $376.99)
Brand notoriety: ASTH and HCA are both not notable
Both companies represent the Hospital/Nursing Management industry
Current volume relative to the 65-day Moving Average: ASTH: 127% vs. HCA: 102%
Market capitalization -- ASTH: $1.96B vs. HCA: $83.63B
ASTH [@Hospital/Nursing Management] is valued at $1.96B. HCA’s [@Hospital/Nursing Management] market capitalization is $83.63B. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $83.63B to $0. The average market capitalization across the [@Hospital/Nursing Management] industry is $4.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASTH’s FA Score shows that 1 FA rating(s) are green whileHCA’s FA Score has 1 green FA rating(s).

  • ASTH’s FA Score: 1 green, 4 red.
  • HCA’s FA Score: 1 green, 4 red.
According to our system of comparison, HCA is a better buy in the long-term than ASTH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASTH’s TA Score shows that 3 TA indicator(s) are bullish while HCA’s TA Score has 4 bullish TA indicator(s).

  • ASTH’s TA Score: 3 bullish, 5 bearish.
  • HCA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, HCA is a better buy in the short-term than ASTH.

Price Growth

ASTH (@Hospital/Nursing Management) experienced а +3.07% price change this week, while HCA (@Hospital/Nursing Management) price change was -3.13% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +0.12%. For the same industry, the average monthly price growth was +5.03%, and the average quarterly price growth was +27.05%.

Reported Earning Dates

ASTH is expected to report earnings on Aug 12, 2026.

HCA is expected to report earnings on Jul 23, 2026.

Industries' Descriptions

@Hospital/Nursing Management (+0.12% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HCA($83.6B) has a higher market cap than ASTH($1.96B). ASTH has higher P/E ratio than HCA: ASTH (64.85) vs HCA (12.99). ASTH YTD gains are higher at: 59.452 vs. HCA (-18.968). HCA has higher annual earnings (EBITDA): 15.7B vs. ASTH (163M). ASTH has less debt than HCA: ASTH (1.07B) vs HCA (49.8B). HCA has higher revenues than ASTH: HCA (76.4B) vs ASTH (3.53B).
ASTHHCAASTH / HCA
Capitalization1.96B83.6B2%
EBITDA163M15.7B1%
Gain YTD59.452-18.968-313%
P/E Ratio64.8512.99499%
Revenue3.53B76.4B5%
Total Cash478MN/A-
Total Debt1.07B49.8B2%
FUNDAMENTALS RATINGS
ASTH vs HCA: Fundamental Ratings
ASTH
HCA
OUTLOOK RATING
1..100
824
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
9
Undervalued
PROFIT vs RISK RATING
1..100
9549
SMR RATING
1..100
8843
PRICE GROWTH RATING
1..100
3863
P/E GROWTH RATING
1..100
1173
SEASONALITY SCORE
1..100
4450

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HCA's Valuation (9) in the Hospital Or Nursing Management industry is somewhat better than the same rating for ASTH (72) in the null industry. This means that HCA’s stock grew somewhat faster than ASTH’s over the last 12 months.

HCA's Profit vs Risk Rating (49) in the Hospital Or Nursing Management industry is somewhat better than the same rating for ASTH (95) in the null industry. This means that HCA’s stock grew somewhat faster than ASTH’s over the last 12 months.

HCA's SMR Rating (43) in the Hospital Or Nursing Management industry is somewhat better than the same rating for ASTH (88) in the null industry. This means that HCA’s stock grew somewhat faster than ASTH’s over the last 12 months.

ASTH's Price Growth Rating (38) in the null industry is in the same range as HCA (63) in the Hospital Or Nursing Management industry. This means that ASTH’s stock grew similarly to HCA’s over the last 12 months.

ASTH's P/E Growth Rating (11) in the null industry is somewhat better than the same rating for HCA (73) in the Hospital Or Nursing Management industry. This means that ASTH’s stock grew somewhat faster than HCA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASTHHCA
RSI
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
65%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
50%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
68%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
63%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
75%
Bearish Trend 2 days ago
59%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 8 days ago
69%
Declines
ODDS (%)
Bearish Trend 9 days ago
77%
Bearish Trend 6 days ago
62%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
47%
Aroon
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
58%
View a ticker or compare two or three
Interact to see
Advertisement
ASTH
Daily Signal:
Gain/Loss:
HCA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XNAV99.260.44
+0.44%
FundX Aggressive ETF
AJUL30.020.02
+0.07%
Innovator Eq Dfnd Prot ETF - 2Yr toJul26
GJP24.24N/A
N/A
Synthetic Fixed Income Securities on the behalf of STRATS for Dominion Resources Series 2005-6
YEAR50.26-0.03
-0.05%
AB Ultra Short Income ETF
PSF19.69-0.11
-0.56%
COHEN & STEERS SELECT PREFERRED AND Income FUND

ASTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASTH has been loosely correlated with SGRY. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ASTH jumps, then SGRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASTH
1D Price
Change %
ASTH100%
+1.00%
SGRY - ASTH
36%
Loosely correlated
-0.07%
ACHC - ASTH
30%
Poorly correlated
+1.33%
HCA - ASTH
30%
Poorly correlated
+0.49%
NHC - ASTH
30%
Poorly correlated
-0.06%
CON - ASTH
28%
Poorly correlated
-0.25%
More

HCA and

Correlation & Price change

A.I.dvisor indicates that over the last year, HCA has been closely correlated with UHS. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if HCA jumps, then UHS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HCA
1D Price
Change %
HCA100%
+0.49%
UHS - HCA
68%
Closely correlated
+1.04%
THC - HCA
59%
Loosely correlated
+3.58%
ENSG - HCA
35%
Loosely correlated
+2.04%
CON - HCA
35%
Loosely correlated
-0.25%
DVA - HCA
31%
Poorly correlated
+0.85%
More